Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
LambdaVision Secures $7M Seed Funding Led by Seven Seven Six and Aurelia Foundry Fund
SeedVenture Capital

LambdaVision Secures $7M Seed Funding Led by Seven Seven Six and Aurelia Foundry Fund

•November 5, 2025
•Nov 5, 2025
0

Participants

LambdaVision

LambdaVision

company

Aurelia Foundry

Aurelia Foundry

investor

Seraphim Space

Seraphim Space

investor

Why It Matters

The infusion of capital accelerates a novel, space‑manufactured eye treatment that could fill a major therapeutic gap in vision‑loss diseases and showcases a new manufacturing model for biotech products.

Deal Summary

LambdaVision, a biotech company developing an artificial retina, announced the close of a $7 million seed round. The round was co‑led by Seven Seven Six and Aurelia Foundry Fund with participation from Seraphim Space, providing runway into 2027 for preclinical development and space‑enabled manufacturing.

0

Comments

Want to join the conversation?

Loading comments...